5/29
01:50 pm
rprx
Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty [Yahoo! Finance]
Low
Report
Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty [Yahoo! Finance]
5/28
07:54 am
rprx
Agios in pact with Royalty Pharma for brain tumor candidate [Seeking Alpha]
Low
Report
Agios in pact with Royalty Pharma for brain tumor candidate [Seeking Alpha]
5/28
07:20 am
rprx
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million [Yahoo! Finance]
Low
Report
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million [Yahoo! Finance]
5/28
07:10 am
rprx
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
Low
Report
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
5/24
01:21 pm
rprx
Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday [Yahoo! Finance]
Low
Report
Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday [Yahoo! Finance]
5/22
04:17 pm
rprx
Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline [Yahoo! Finance]
Low
Report
Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline [Yahoo! Finance]
5/22
04:10 pm
rprx
Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
Low
Report
Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
5/22
09:37 am
rprx
The Leukemia & Lymphoma Society is Accepting Applications for Up to $2.5 Million in Funding Through its Equity in Access Research Program [Yahoo! Finance]
Low
Report
The Leukemia & Lymphoma Society is Accepting Applications for Up to $2.5 Million in Funding Through its Equity in Access Research Program [Yahoo! Finance]
5/13
08:15 am
rprx
Royalty Pharma to Present at Upcoming Investor Conferences
Low
Report
Royalty Pharma to Present at Upcoming Investor Conferences
5/12
09:28 am
rprx
Here's What Analysts Are Forecasting For Royalty Pharma plc (NASDAQ:RPRX) After Its First-Quarter Results [Yahoo! Finance]
Low
Report
Here's What Analysts Are Forecasting For Royalty Pharma plc (NASDAQ:RPRX) After Its First-Quarter Results [Yahoo! Finance]
5/11
09:34 am
rprx
Only Four Days Left To Cash In On Royalty Pharma's (NASDAQ:RPRX) Dividend [Yahoo! Finance]
Low
Report
Only Four Days Left To Cash In On Royalty Pharma's (NASDAQ:RPRX) Dividend [Yahoo! Finance]
5/11
12:15 am
rprx
Royalty Pharma plc (NASDAQ: RPRX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Royalty Pharma plc (NASDAQ: RPRX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
5/10
02:51 pm
rprx
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/9
04:44 pm
rprx
5 Best Undervalued Stocks To Buy In May 2024 [Forbes]
Low
Report
5 Best Undervalued Stocks To Buy In May 2024 [Forbes]
5/9
01:47 pm
rprx
Royalty Pharma (RPRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Low
Report
Royalty Pharma (RPRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
5/9
07:06 am
rprx
Royalty Pharma Reports First Quarter 2024 Results [Yahoo! Finance]
Low
Report
Royalty Pharma Reports First Quarter 2024 Results [Yahoo! Finance]
5/9
07:00 am
rprx
Royalty Pharma Reports First Quarter 2024 Results
Low
Report
Royalty Pharma Reports First Quarter 2024 Results
5/9
06:52 am
rprx
Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab [Yahoo! Finance]
Low
Report
Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab [Yahoo! Finance]
5/9
06:45 am
rprx
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
Low
Report
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
5/6
10:48 am
rprx
Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics [Yahoo! Finance]
Low
Report
Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics [Yahoo! Finance]
5/4
09:21 am
rprx
Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21 [Yahoo! Finance]
Low
Report
Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21 [Yahoo! Finance]
5/2
04:13 pm
rprx
Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma [Yahoo! Finance]
Low
Report
Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma [Yahoo! Finance]
4/20
08:49 am
rprx
Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21 [Yahoo! Finance]
Medium
Report
Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21 [Yahoo! Finance]
4/19
08:15 am
rprx
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Low
Report
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
4/17
08:15 am
rprx
Royalty Pharma Declares Second Quarter 2024 Dividend
Low
Report
Royalty Pharma Declares Second Quarter 2024 Dividend